Evidence map›Paper›PMID 32151335›Full record

ArticleLancet (London, England)2020

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.

Huijun Chen, Juanjuan Guo, Chen Wang, Fan Luo, Xuechen Yu, Wei Zhang, Jiafu Li, Dongchi Zhao, Dan Xu, Qing Gong and 4 more

Erratum issued 4 registry-linked trialsOpen access · bronzeAbstract readCase Reports
In one paragraph

Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 4 registered trials, which are not on this map. Cited by 1,693 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,693citing papers in PubMed, 3 pooled it
374.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04353141 unknown statusnot on this map

A Prospective International Lung UltraSound Analysis (ILUSA) Study in Tertiary Maternity Wards During the SARS-CoV-2 Pandemic

TypeobservationalSponsorKU LeuvenRan2020 to 2020Enrolled1,850ConditionsCOVID, Pregnancy Complications, Infectious, Pregnancy Related, Pregnancy, High RiskArmsstandardized Lung Ultrasound (LUS) examination
NCT04354441 phase2withdrawnnot on this map

Randomized Trial Evaluating Effect of Outpatient Hydroxychloroquine on Reducing Hospital Admissions in Pregnant Women With SARS-CoV-2 Infection: HyPreC Trial

TypeinterventionalSponsorSir Mortimer B. Davis - Jewish General HospitalRan2020 to 2020Enrolled0ConditionsCOVID-19, SARS-CoV-2, Pregnant Women, HydroxychloroquineArmshydroxychloroquine sulfate 200 MG, Placebo oral tablet
NCT04418557 completednot on this map

COVID-19 and Obstetric Transmission

Typeobservational_patient_registrySponsorUniversity Hospitals Cleveland Medical CenterRan2020 to 2021Enrolled64ConditionsCOVID, Pregnancy ComplicationsArmsRT-PCR and antibody testing
NCT05175755 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Genetic Risk Factors Predictive of the Occurrence of Maternally Diagnosed Perinatal Depression in Women

TypeinterventionalSponsorFondation Hôpital Saint-JosephRan2023 to 2024Enrolled3,000ConditionsPerinatal DepressionArmsPatients
3 · Its place in the literature

Who cites it

1,693 citing papers in PubMed, 3 syntheses or guidelines pooled it, 4,017 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neonatal pulmonary function tests in infants born to COVID-19 positive mothers.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Coronavirus disease 2019-associated liver injury in pregnancy: A case report.The Journal of international medical research · 2025
    Article
  20. Article

1,633 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Huijun ChenDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Juanjuan GuoDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Chen WangDepartment of Obstetrics and Gynaecology, Peking University First Hospital, Beijing, China.
Fan LuoState Key Laboratory of Virology/Institute of Medical Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China.
Xuechen YuDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Wei ZhangDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Jiafu LiDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Dongchi ZhaoDepartment of Paediatrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Dan XuDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Qing GongDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Jing LiaoDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China.
Huixia YangDepartment of Obstetrics and Gynaecology, Peking University First Hospital, Beijing, China. Electronic address: yanghuixia@bjmu.edu.cn.
Wei HouState Key Laboratory of Virology/Institute of Medical Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, Hubei, China. Electronic address: houwei@whu.edu.cn.
Yuanzhen ZhangDepartment of Gynaecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China; Clinical Medicine Research Centre of Prenatal Diagnosis and Birth Health in Hubei Province, Wuhan, Hubei, China. Electronic address: zhangyuanzhen@whu.edu.cn.
Zhongnan Hospital of Wuhan University · CNWuhan University · CNHubei Provincial Women and Children's Hospital · CNPeking University First Hospital · CNNorthwestern University · USWuhan Institute of Virology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. Limited data are available for pregnant women with COVID-19 pneumonia. This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection.

methodsClinical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant women with laboratory-confirmed COVID-19 pneumonia (ie, with maternal throat swab samples that were positive for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan 20 to Jan 31, 2020. Evidence of intrauterine vertical transmission was assessed by testing for the presence of SARS-CoV-2 in amniotic fluid, cord blood, and neonatal throat swab samples. Breastmilk samples were also collected and tested from patients after the first lactation.

findingsAll nine patients had a caesarean section in their third trimester. Seven patients presented with a fever. Other symptoms, including cough (in four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also observed. Fetal distress was monitored in two cases. Five of nine patients had lymphopenia (<1·0 × 10⁹ cells per L). Three patients had increased aminotransferase concentrations. None of the patients developed severe COVID-19 pneumonia or died, as of Feb 4, 2020. Nine livebirths were recorded. No neonatal asphyxia was observed in newborn babies. All nine livebirths had a 1-min Apgar score of 8-9 and a 5-min Apgar score of 9-10. Amniotic fluid, cord blood, neonatal throat swab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negative for the virus.

interpretationThe clinical characteristics of COVID-19 pneumonia in pregnant women were similar to those reported for non-pregnant adult patients who developed COVID-19 pneumonia. Findings from this small group of cases suggest that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy.

fundingHubei Science and Technology Plan, Wuhan University Medical Development Plan.

Indexed as

BetacoronavirusInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousCesarean SectionCoronavirus InfectionsCoughCOVID-19DyspepsiaFemaleFeverHumansInfant, NewbornMyalgiaPharyngitisPneumonia, ViralPregnancy

Identifiers

PMID32151335
PMCPMC7159281
OpenAlexW3005679569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.